W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

News

16 August, 2022
Opinion of the Transparency Council – health policy programme on infertility treatment (Rzeszów)
read more
16 August, 2022
Opinion of the Transparency Council – health policy programme on breast cancer (Municipality of Toszek)
read more
16 August, 2022
Position of the Transparency Council – Inovelon (rufinamide)
read more
16 August, 2022
Position of the Transparency Council – Fycompa (perampanel)
read more
16 August, 2022
Opinion of the Transparency Council – changes to the drug programme B.82
read more
16 August, 2022
Opinion of the Transparency Council – active substance etanercept
read more
16 August, 2022
Opinion of the Transparency Council – changes to the drug programme B.44
read more
16 August, 2022
Position of the Transparency Council – Ozurdex (dexamethasone)
read more
12 August, 2022
Position of the Transparency Council – Tremfya (guselkumab)
read more
12 August, 2022
Position of the Transparency Council – Suliqua (insulinum glarginum + lixisenatidum)
read more
12 August, 2022
Position of the Transparency Council – Onureg (azacitidine)
read more
12 August, 2022
Communication on the meeting of the Tariff Council on 28.07.2022
read more
12 August, 2022
Communication on the meeting of the Tariff Council on 21.07.2022
read more
09 August, 2022
More than PLN 18 billion for, among other things, minimum wage increases. Additionally, an increase in the lump sum payment and higher valuation of internal medicine healthcare services
read more
08 August, 2022
Press conference – implementation of the Act on the manner of determining the lowest basic salary for employees employed in healthcare entities
read more
05 August, 2022
The Meeting of the Transparency Council No. 32/2022 of 16.08.2022
read more
05 August, 2022
Communication – Data acquisition for gastroscopy performed in outpatient settings
read more
04 August, 2022
The Meeting of the Transparency Council No. 31/2022 of 11.08.2022
read more
02 August, 2022
The Meeting of the Tariffs Council No. 19/2022 of 11.08.2022
read more
01 August, 2022
Opinion of the President – Breast cancer prevention programme – ultrasound examination for women aged 30 to 49 from the town of Sieradz
read more
28 July, 2022
The Meeting of the Transparency Council No. 30/2022 of 01.08.2022.
read more
28 July, 2022
Recommendation of the President – Yervoy (ipilimumab) in combination with Opdivo (nivolumab)
read more
28 July, 2022
Recommendation of the President – Opdivo (nivolumab) in combination with Yervoy (ipilimumab)
read more
26 July, 2022
Opinion of the Transparency Council – health policy programme on therapeutic rehabilitation (town of Żyrardów)
read more

Home page

News Publications Publikacje BIP

#webinar agenda Aktualności announcement of the President azathioprinum Bimzelx Collegium AOTMiT colorectal cancer communication Communication from the Transparency Council Communication on the Tariff Council Cost Accounting Standard Council for Tariffs Affairs covering neonatal care cyclophosphamidum Data acquisition dental treatment services diseases of the organ of vision drug programme Empliciti entecavirum etanercept Fycompa gastroscopy glaucoma health policy program health policy programme health policy programme on breast cancer health policy programme on infertility treatment Health Policy Programmes Impavido in vitro Inovelon Jardiance Meeting of the Transparency Council methotrexatum Milupa Basic-P minimum wage increases mycophenolate mofetil new new tariffs news Notice Notice of the President Ontozry Onureg Opdivo Opdivo (nivolumab)opinion Opinion of the President Opinion of the Transparency Council Ospolot Ozurdex perinatal care Ponvory Position of the Transparency Council Press conference Recommendation Recommendation of the President Renastep report Rezurock sirolimus Suliqua Tariff Council Tariffs Council Tarification Plan 2025 tenofovirum disoproxilum the drug programme B.44 the drug programme B.82 The Meeting of the Tariffs Council trainings Transparency Council Tremfya update Vivitrol Yervoy

Pokaż więcej ↓

Pokaż mniej ↑

Telefon

Page header

News

Opinion of the Transparency Council – health policy programme on infertility treatment (Rzeszów)

Opinion of the Transparency Council – health policy programme on breast cancer (Municipality of Toszek)

Position of the Transparency Council – Inovelon (rufinamide)

Position of the Transparency Council – Fycompa (perampanel)

Opinion of the Transparency Council – changes to the drug programme B.82

Opinion of the Transparency Council – active substance etanercept

Opinion of the Transparency Council – changes to the drug programme B.44

Position of the Transparency Council – Ozurdex (dexamethasone)

Position of the Transparency Council – Tremfya (guselkumab)

Position of the Transparency Council – Suliqua (insulinum glarginum + lixisenatidum)

Position of the Transparency Council – Onureg (azacitidine)

Communication on the meeting of the Tariff Council on 28.07.2022

Communication on the meeting of the Tariff Council on 21.07.2022

More than PLN 18 billion for, among other things, minimum wage increases. Additionally, an increase in the lump sum payment and higher valuation of internal medicine healthcare services

Press conference – implementation of the Act on the manner of determining the lowest basic salary for employees employed in healthcare entities

The Meeting of the Transparency Council No. 32/2022 of 16.08.2022

Communication – Data acquisition for gastroscopy performed in outpatient settings

The Meeting of the Transparency Council No. 31/2022 of 11.08.2022

The Meeting of the Tariffs Council No. 19/2022 of 11.08.2022

Opinion of the President – Breast cancer prevention programme – ultrasound examination for women aged 30 to 49 from the town of Sieradz

The Meeting of the Transparency Council No. 30/2022 of 01.08.2022.

Recommendation of the President – Yervoy (ipilimumab) in combination with Opdivo (nivolumab)

Recommendation of the President – Opdivo (nivolumab) in combination with Yervoy (ipilimumab)

Opinion of the Transparency Council – health policy programme on therapeutic rehabilitation (town of Żyrardów)